News for Neurocrine Biosciences, Inc. (0K6R.L)

The FDA has approved 43 novel drugs so far this year (January-November), compared to 52 during the same period last year. As we step into the final month of the year, let's take a look at the biotech companies whose drugs are under regulatory review in the U.